Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assay human aqueous for bimatoprost and the presence of any
metabolites, especially prostaglandin analogs. Hypothesis:Bimatoprost is not metabolized to a
prostaglandin F-2-alpha analog in human eyes
- Bimatoprost levels in human aqueous peak approximately three hours post dosing